Development and Validation of Oral Bleeding Risk Scoring System (OBRS) for Predicting Post-tooth-extraction Bleeding in Patients Undergoing Treatment with Warfarin: A Single Centre Study by FUKUZAWA Satoshi et al.
Development and Validation of Oral Bleeding
Risk Scoring System (OBRS) for Predicting
Post-tooth-extraction Bleeding in Patients
Undergoing Treatment with Warfarin: A Single
Centre Study
著者名 FUKUZAWA Satoshi, HOSHI Keika, OKAMOTO
Toshihiro, ANDO Tomohiro
journal or
publication title
Tokyo Women's Medical University Journal
volume 3
page range 1-10
year 2019-12-20
URL http://hdl.handle.net/10470/00032472
doi: https://doi.org/10.24488/twmuj.2018001|10.24488/twmuj.2018001
―1―
Original
TWMUJ 3: 1-10, 2019
Development and Validation of Oral Bleeding Risk Scoring System (OBRS) for
Predicting Post-tooth-extraction Bleeding in Patients Undergoing Treatment
with Warfarin: A Single Centre Study
Satoshi Fukuzawa,１Keika Hoshi,２Toshihiro Okamoto,１ and Tomohiro Ando１
１
Department of Oral and Maxillofacial Surgery, School of Medicine, Tokyo Women’s Medical University, Tokyo, Japan
２
Department of Hygiene, Kitasato University School of Medicine, Japan
(Accepted October 29, 2018)
(Advance Publication by J-STAGE February 7, 2019)
Introduction: This study aimed to develop an oral bleeding risk scoring system (OBRS) for predicting the post-tooth-
extraction bleeding risk in patients medicated with warfarin.
Materials and Methods: We included a derivation cohort of 211 consecutive inpatients from April 1, 2013 to March 31,
2015 and a validation cohort of 63 consecutive inpatients from April 1, 2015 to March 31, 2016 who underwent tooth extrac-
tion at Tokyo Women’s Medical University hospital. Post-tooth-extraction bleeding was observed in 29 (13.7%) cases in the
derivation cohort. Using multivariate logistic analysis, three predictors (international normalized ratio of prothrombin time:
PT-INR, drugs, incision) were selected for the final model.
Results: OBRS was derived as follows: PT-INR×2+drugs+incision. Receiver operating characteristic curves provided area
under the curve of 0.77 (95%CI, 0.67 to 0.85) for OBRS, 0.61 (95% CI, 0.50 to 0.71) for HAS-BLED score, and 0.69 (95%
CI, 0.56 to 0.79) for PT-INR. The high-risk cut-off OBRS value was 5.08 points. Post-tooth-extraction bleeding was ob-
served in 9 (14.2%) cases in the validation cohort. Sensitivity and specificity were 100% and 90.7%, respectively. The OBRS
showed excellent performance with respect to predictor score.
Conculusions: The proposed OBRS showed good performance for predicting post-tooth extraction bleeding in patients un-
dergoing warfarin treatment.
Key Words: tooth extraction, risk score, warfarin, bleeding
Introduction
Reducing the risk of oral bleeding in patients undergoing
warfarin treatment is essential in clinical practice. How-
ever, an effective predictive scoring system has not been
developed to date. Discontinued warfarin administration
preoperatively reduces the risk of post-tooth-extraction
bleeding; however, this approach is not feasible in clini-
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Table　1　HAS-BLED score.
HAS-BLED bleeding risk score Risk factor clinical characteristics
H: Hypertension Uncontrolled, >160 mmHg systolic
A: Abnomal renal or liver function (1 point each) A1: Presence of chronic dialysis,
renal transplantation or serum
creatinine ≥200 μmol/L
A2: Chronic hepatic disease (e.g., cirrhosis),
bilirubin >2 × upper limit of normal
AST/ALT/ALP >3 × upper limit of normal
S: Stroke Previous history
B: Bleeding Bleeding history or predisposition
L: Labile INRs Unstable/high INRs or poor time
in therapeutic range (eg, <60%)
E: Elderly >65 years
D: Drugs or alcohol (1 point each) D1: Concomitant antiplatelet agents or NSAIDs
D2: Alcohol excess
Alcohol excess, Criteria from the European Society of Cardiology 23 were used.
ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; 
NSAIDs, non-steroidal anti-inflammatory drugs.
cal settings.
Wahl reported that among at least 2,673 patients
whose warfarin dose was reduced or withdrawn for at
least 2,775 visits to dental procedure, 22 patients devel-
oped embolic complications (0.8% of cessations), includ-
ing 6 fatal events (0.2% of cessations).
１
Therefore, pa-
tients scheduled to undergo tooth extraction who have
achieved target international normalized ratio of
prothrombin time (PT-INR) should not stop the warfarin
treatment.
２，３
According to the guidelines issued in the UK, patients
undergoing warfarin therapy should not stop medication
prior to tooth extraction if their PT-INR is stable. With
respect to risk assessment, serious haemorrhagic compli-
cations of post-tooth-extraction bleeding are unlikely in
patients with PT-INR values in the therapeutic range of
2.0-4.0.
４
In Japan, the Guidelines for Patients on Antithrom-
botic Therapy Requiring Dental Extraction recommended
a PT-INR of 3.0 as the maximum safety threshold for
tooth extraction.
５
However, studies have indicated that
some patients with controlled PT-INR of <3.0 developed
post-tooth-extraction bleeding.
６-８
The usefulness and accuracy of evaluation based
solely on the PT-INR are limited; therefore, evaluating
the interaction of warfarin and other relevant factors pre-
operatively is necessary. In this study, we proposed oral
bleeding risk scoring system (OBRS) for predicting post-
tooth-extraction bleeding risk in patients undergoing war-
farin treatment, which would enable improved hospitali-
zation management and postoperative haemostasis, and
help prevent complications.
In the recent years, HAS-BLED score (Table 1) has
been used as an index for evaluating bleeding risk in pa-
tients with atrial fibrillation (AF) undergoing anticoagu-
lant therapy.
９
HAS-BLED score was developed based on
evaluation of 3,978 patients in the Euro Heart Survey on
AF, which aimed to assess the individual bleeding risk of
patients with AF, and aid in making clinical decision re-
garding antithrombotic therapy in patients.
９
The score
evaluates 9 items that potentially contribute to patients’
overall potential bleeding risk, and subsequently, ranks
patients according to their rate of risk of major bleeding
episode in the following year.
Therefore, a scoring system that predicts patients’
post-tooth-extraction bleeding risk is necessary. This
study aimed to develop a novel and simple OBRS for
predicting the post-tooth-extraction bleeding risk in pa-
tients under warfarin treatment.
Materials and Methods
1. Study design
The study was a retrospective cohort study. The Ethics
Committee of Tokyo Women’s Medical University, To-
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Table　2　Baseline characteristics of the derivation and validation cohorts.
Derivation cohort
group
 (n=211) 
Validation Cohort
group
 (n=63) 
p value
*p<0.05
Patient
Men, n (%) 112 (53) 32 (51) 0.74
Median age 72 71 0.39
Age>65 y, n (%) 154 (73) 52 (83)   <0.001*
Medical history
Hypertension, n (%)  28 (13) 20 (32)   <0.001*
Chronic kidney disease, n (%)  21 (10) 4 (6) 0.39
Chronic liver disease, n (%)  0 (0) 0 (0) 
Stroke, n (%)  38 (18)  9 (11) 0.49
Bleeding history, n (%)  9 (4) 2 (3) 0.7
Drugs, n (%)  59 (28) 14 (22) 0.37
Labial INR, n (%) 11 (5) 1 (2) 0.24
PT-INR 2.01±0.99 2.01±0.42 0.99
HAS-BLED Score (points) 1.43±0.45 1.56±0.96 0.34
Local factor
Incision, n (%)  54 (26) 23 (37) 0.09
Bone milling, n (%)  64 (30) 17 (27) 0.06
Number of extracted teeth (mean±SD)  2.3±2.11 1.63±1.26  0.03*
kyo, Japan, approved the study (approval code: 3909-R).
2. Study population and eligibility criteria
The study subjects included 274 consecutive Japanese
inpatients (144 men and 130 women; average age: 68.9
years) at the Department of Oral and Maxillofacial Sur-
gery, Tokyo Women’s Medical University Hospital, who
underwent tooth extraction between April 1, 2013 and
March 31, 2016 while receiving a maintenance dose of
warfarin. Of these patients, 211 cases were included in
the derivation cohort ( early phase : April 1, 2013 to
March 31, 2015) and 63 cases in the validation cohort
(late phase: April 1, 2015 to March 31, 2016) (Table 2).
In all cases, we performed inpatient tooth extraction
while continuing orally administered warfarin; in addi-
tion, concomitant antiplatelet agents were continued at
the maintenance dose. Exclusion criteria were: age of <
20 years old at time of hospital admission, presence of
comorbid blood diseases, and PT-INR level of 3.5, as
indicated by results of blood tests performed on the day
prior to tooth extraction. Patients underwent follow-up
examinations of oral wound healing for 2 weeks period
after discharge. Doctors’ and nurses’ records obtained
from the electronic medical records were registered along
with the clinical data in a combined database. All patients
who were hospitalized and underwent multiple tooth ex-
tractions during the study period, were included in the
analysis.
3. HAS-BLED score
The acronym HAS-BLED stands for Hypertension,
Abnormal renal or liver function, Stroke, Bleeding,
Labile international normalized ratio (INRs), Elderly and
Drugs or alcohol. Patients with systolic blood pressure of
160 mmHg, at the time of arrival at the hospital, were
categorized as having hypertension. Patients were cate-
gorized as having abnormal renal or liver function based
on the following conditions: receiving haemodialysis or
underwent kidney transplant ; with a serum creatinine
level 2.26 mg/dL in the most recent blood test; with
chronic liver diseases, such as liver cirrhosis, and biliru-
bin levels at least two times the normal upper limit in
most recent blood test; and with at least three times the
normal upper limit of either alanine transaminase, aspar-
tate aminotransferase, or alkaline phosphatase levels in
most recent blood test. Patients were categorized as hav-
ing a stroke or bleeding based on information obtained
from medical interviews on hospital admission. Labile
INRs indicated patients with unstable or high INRs or
poor clotting time in the therapeutic range (time in thera-
peutic range <60% of recommended value). In this study,
cases in which control of warfarin was necessary for
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tooth extraction with high INR (PT-INR 3.5) by outpa-
tient examination were defined as labile INRs. Patients
who were65 years of age at the time of tooth extraction
were categorized as elderly. Patients with medical history
of long-term administration of antiplatelet agents or non-
steroidal anti-inflammatory drugs (NSAIDs) or patients
with alcohol dependency were included in the drug and
alcohol category. One point was allocated for each of
these categories, with maximum possible score of 9
points.
4. Tooth extraction procedure
Each patient’s primary physician was consulted preop-
eratively regarding his or her general medical status and
history of use of anticoagulants. In patients presenting
with acute symptoms, such as periodontal abscesses, api-
cal periodontitis, or pericoronitis, around the tooth to be
extracted, procedures such as incision and drainage were
performed as necessary and antibiotics were prescribed
for at least 3 days. The patients’ meals were limited in
amounts of vitamin K. During tooth extraction, electro-
cardiogram, blood pressure, pulse rate, and percutaneous
oxygen saturation levels were monitored. For Local an-
aesthesia, 1.8-3.6 mL of 2.0% lidocaine containing 1 /
80,000 units of epinephrine (Ora Injection Dental Car-
tridge, Showa Yakuhin Kakou Co., Tokyo, Japan), was
administered. Minimally invasive tooth extraction was
performed. In cases with indication of multiple teeth to
be extracted were spread over1/3rd of total jaw area, all
teeth were extracted in one procedure; and when teeth to
be extracted were spread over 1/3rd of total jaw area,
multiple teeth were usually extracted in one procedure if
the procedure was expected to last 30 min. The proce-
dure was conducted under consideration of patients’ age
and presence of any comorbid disease. After extraction,
curettage of inflammatory granulation tissue around the
wound border was performed, haemostatic gelatin
sponge (Spongel, Astellas Pharma Inc. , Tokyo, Japan)
was inserted into the socket, and suturing was performed
to reduce size of the wound border. The patient was re-
quested to bite down on a piece of absorbent cotton for
20 min after completion of tooth extraction, in order to
achieve pressure haemostasis. At 30 min after tooth ex-
traction, the patient was examined to confirm cessation
of bleeding. After extraction, patients were instructed to
avoid strong or frequent gargling and to rest as much as
possible. Post-extraction meals comprised gruel-like
food. If patients experienced pain after tooth extraction,
they were administered acetaminophen, 1500 mg/day.
5. Post-tooth-extraction bleeding
Post-tooth-extraction bleeding was defined that pa-
tients who underwent any medical haemostatic procedure
were categorized as having bleeding. Haemostatic proce-
dures performed under examining oral surgeons’ decision
are described below. In case of moderate-to-severe bleed-
ing that was difficult to resolve using primary haemosta-
sis alone, local dental anaesthetic containing 1 /80,000
epinephrine, which has vasoconstrictive effects, was in-
filtrated at dose of 1.0-1.8 mL around the tooth extraction
wound. Pressure was applied to the wound by instructing
patients to bite down on a piece of gauze or absorbent
cotton. Nevertheless, if insufficient control of bleeding
was determined, injection of additional local haemostatic
agent(s) or additional suturing of the wound was per-
formed as necessary. For patients with repeated bleeding
or prolonged exudative bleeding after undergoing hae-
mostatic procedures, haemostatic splint was fabricated to
cover the wound after lining with periodontal pack or
denture-based tissue conditioner.
Patients who exhibited bleeding but in for who haemo-
static procedures were deemed unnecessary were in-
structed to rest adequately and refrain from excessive
gargling. Patients with mild bleeding and oozing, were
requested to bite down for 20 min on a piece of gauze or
absorbent cotton placed on the tooth extraction wound, to
achieve pressure haemostasis. Regular follow-up exami-
nations were performed by oral surgeons twice a week,
and involved complete assessment of wound healing. Pa-
tients who did not require further treatment for post-
tooth-extraction bleeding were categorized as “no bleed-
ing group.”
6. Risk factors
For determining risk factors, we analyzed data of both
HAS-BLED score factors and local factors. Data collec-
tion and analysis included evaluation of local factors
such as the number of teeth extracted in one procedure,
gingival incision, and cutting the alveolar bone. An inci-
sion indicates that a gingival incision is made during
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tooth extraction. Drug definition was 1 point by using an-
tiplatelet drugs or using NSAIDs. Alcohol addiction was
also defined as 1 point separately.
7. Statistical analysis
The subjects were divided into two groups: patients
who experienced post-tooth-extraction bleeding (bleed-
ing); and patients who did not, experience post-tooth-
extraction bleeding (no bleeding); and patients’ charac-
teristics were compared between groups. Continuous
variables were examined using Welch’s t-test. Nominal
variables were examined using Fisher’s exact test. The
significance level (p) was 0.05. Based on the results ob-
tained, forced-entry multivariate logistic regression
analysis was performed on significant factors. Bootstrap
method was used to assess discrimination, in which
1,000 random samples were drawn with replacements
from the original dataset.
Subsequently, parameter estimates from analysis were
scored to create optimum OBRS formula. Receiver oper-
ating characteristic (ROC) curves were created to com-
pare OBRS with each PT-INR and HAS-BLED to deter-
mine significant predictor of post-tooth-extraction bleed-
ing. For statistical analysis, JMP Pro12 (SAS Institute
Inc., Cary, NC, USA) and Statistical Package for the So-
cial Sciences (SPSS) software version 22.0 (Chicago, IL,
USA) were used.
Results
1. Study population
Thirty-eight patients (13.9% 38/274 cases) met the
definition of bleeding cases. We included 28 cases
(13.7% 29/211 cases) in the derivation cohort, and nine
cases (14.3% 9/63 cases) in the validation cohort. Re-
garding the timing of the post-tooth-extraction bleedings,
there were 28 cases within 24 hours after tooth extrac-
tion, 5 cases for 1 to 3 days, and 5 cases for 4 to 7 days.
There were 8 cases of additional prescriptions of antibiot-
ics and formulation of acetaminophen to pain with bleed-
ing, but only 3 cases bleeding newly after prescription.
Haemostasis with localized haemostatics procedure was
performed in all patients with post-tooth-extraction
bleedings, and there was no mortality from haemorrhage.
Derivation cohort and Validation Cohort in the patient
group showed a significant difference in age and hyper-
tension in both groups, but no significant difference was
found in other factors (Table 2). There was no alcohol-
ism in this patient group. We defined drugs as either
long-term administration of antiplatelet agents or
NSAIDs.
2. Predictors for the post-tooth-extraction bleedings
We examined the association between the candidate
predictors and the post-tooth-extraction bleedings in mul-
tivariable logistic regression. The association of post-
tooth-extraction bleeding is shown Table 3 in the deriva-
tion cohort. Drugs were adopted without adopting the
HAS-BLED score because significant differences were
found only in drugs by factor of HAS-BLED score. The
final model predictors included PT-INR, drugs and inci-
sion (Table 3).
Logistic regression analysis showed that PT-INR,
drugs, incision were independent variable for predicting
tooth extraction bleeding (Table 4).
Using JMP, estimates for each item were as follows:
PT-INR, 2.1; drugs, 1.1; and incision, 1.3. We performed
model examination through bootstrap method. The com-
parison between the bootstrapped model and the simple
logistic model showed a similar regression coefficient for
each variable and no change beta coefficient (Table 5).
Estimate ratios were calculated using the lowest esti-
mate (drugs) as reference: drugs (1.1/1.1=1), PT-INR
(2.1/1.1=1.9), and incision (1.3/1.1=1.2). The ratio of the
score was calculated from the odds ratio in the logistic
regression analysis (Table 5).
The resulting formula ( formula 1 =PT-INR×1.9＋
drugs×1＋incision×1.2 was compared to a simplified
formula (formula 2=PT-INR×2＋drugs×1＋incision×
1). AUC for formula 1 was 0.76 (95%CI, 0.66 to 0.84),
and for formula 2, 0.77 (95% CI, 0.67 to 0.85), without
significant difference (Figure 1 shows ROC graph com-
paring the two formula). Therefore, formula 2 was se-
lected for use in OBRS (Table 6).
Figure 2 shows ROC graph comparing OBRS with
each HAS-BLED and PT-INR. AUC of OBRS was 0.77
(95% CI, 0.67 to 0.85), HAS-BLED, 0.61 (95% CI, 0.50
to 0.71), and PT-INR, 0.69 (95% CI, 0.56 to 0.79). AUC
of OBRS was statistically significant compared to those
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Table　3　Patient characteristics of the derivation cohort.
Total
patients
 (n=211) 
Bleeding
group
 (n=29) 
No bleeding
group
 (n=182) 
p value
*p<0.05
Patient
Men, n (%) 112 (53) 20 (69)  92 (51) 0.07
Median age 72 68 72 0.39
Age>65 y, n (%) 154 (73) 21 (72) 133 (73) 0.94
Medical history
Hypertension, n (%)  28 (13)  4 (14)  24 (13) 0.56
Chronic kidney disease, n (%)  21 (10)  5 (17) 16 (9) 0.14
Chronic liver disease, n (%)  0 (0) 0 (0)  0 (0) 
Stroke, n (%)  38 (18)  9 (31)  29 (16) 0.93
Bleeding history, n (%)  9 (4) 2 (7)  7 (4) 0.11
Drugs, n (%)  59 (28) 13 (45)  46 (25)  0.03*
Alcoholism, n (%)  0 (0) 0 0
Labial INR, n (%) 11 (5)  3 (10)  8 (4) 0.18
PT-INR 2.01±0.99 2.31±0.56 1.96±0.41   0.001*
HAS-BLED Score (points) 1.43±0.45 1.79±1.08 1.38±0.96  0.04*
Local factor
Incision, n (%)  54 (26) 12 (41)  42 (23)  0.04*
Bone milling, n (%)  64 (30) 16 (55)  48 (26) 0.16
Number of extracted teeth (mean±SD)  2.3±2.11    3±2.35  2.2±2.06 0.69
Table　4　Logistic regression model.
Odds ratio 95% CI Score points p value
PT-INR 7.9  3.1-22.3 2 < 0.001*
Incision 3.7 1.5-9.5 1   0.0056*
Drugs 2.9 1.2-7.1 1   0.0196*
CI, confidence interval. *p<0.05
Table　5　Model comparison after bootstrapping.
B
B
95% CI
Bootstrapped
B
Bootstrapped
B 95% CI
PT-INR  2.1  1.1 to 3.1  2.1  1.1 to 3.4
Incision  1.3 0.39 to 2.2  1.3 0.34 to 2.3
Drugs  1.1 0.17 to 2.0  1.1 0.20 to 2.0
Constant -7.0   -10 to -5.0 -7.0   -10 to -5.0
CI, confidence interval; PT-INR, international normalized ratio of 
prothrombin time; B, beta coefficient.
AUC of PT-INR and HAS-BLED (Figure 2).
Thus, OBRS showed significantly improved ability to
predict post-tooth-extraction bleeding compared with
each PT-INR and HAS-BLED score.
Subsequently, OBRS values were set and compared to
HAS-BLED score. ROC curve indicated cut-off value of
5.08 points.
3. Model performance
For temporal validation, we examined model perform-
ance in validation cohort, which included recently treated
patients in the late phase (Table 7) . Bleeding event at
cut-off value of OBRS was examined. Sensitivity and
specificity were 100% and 90.7%, respectively, for cut-
off score of 5.08 points (Figure 3). OBRS had excellent
performance in terms of predictor score.
Discussion
Reports indicated that incidence of post-tooth-extraction
bleeding in patients with warfarin tranged between 0.6
and 22.8%.
１，６，７，１０
Our results indicated incidence rate of
13.9%.
Despite relatively high incidence rate of post-tooth-
extraction bleeding since subjects of the present study
were hospitalized, patients may have complained about
trivial amounts of bleeding under this environment ;
hence, higher number of haemostatic procedures may
have been performed, which may explain result of high
incidence of bleeding.
It is not practical or advisable to discontinue use of
warfarin in patients who are scheduled to undergo tooth
extractions,
１１
since such discontinuation could lead to
systemic complications. Scoring systems such as HAS-
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Figure　1　Receiver operating characteristic curve of formula 1 vs. formula 2.
p=0.23
S
Table　6　OBRS definition.
Element Definition Score points
PT-INR PT-INR, international normalized ratio of prothrombin time PT-INR value × 2 points
Drugs Concomitant antiplatelet agents or NSAIDs 1 point
Incision The surgeon needed an incision for tooth extraction 1 point
BLED, which were developed for use in patients with
AF, are not accurate in predicting post-tooth-extraction
bleeding, as they do not relate to local and specific fac-
tors. Kataoka et al reported that HAS-BLED score was
not effective to predict risk of bleeding following tooth
extraction.
１２
We analysed the association of post-tooth-
extraction bleeding with each item in the HAS-BLED
score. Significant differences were found between bleed-
ing and no bleeding groups with regard to PT-INR,
drugs, incision, and HAS-BLED score (Table 3). Since
HAS-BLED score includes both PT-INR and drugs, we
included the two subcategories without including the
overall HAS-BLED score in OBRS.
Care was taken to include specific local and dental fac-
tors in OBRS. We combined categories of PT-INR and
drugs which were significant (for tooth extractions) items
of HAS-BLED with local dental factors, such as incision.
Although tooth extraction can involve several elements,
such as necessity for lifting the mucoperiosteal flap or re-
moving the alveolar bone, statistical analysis revealed in-
cision and subsequent suturing had significant impact on
risk of post-tooth-extraction bleeding in patients under-
going warfarin treatment. As part of developing OBRS,
we evaluated the risk ratio, and determined the cut-off
value of 5.08 points, which indicated that complicated
exodontia requiring incisions in patients administered an-
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Figure　2　Receiver operating characteristic curve of HAS-BLED score vs. OBRS.
PT-INR, international normalized ratio of prothrombin time; OBRS, oral bleeding risk scoring system.
p=0.37
p=0.035*
p=0.009*
*p<0.05
S
Table　7　Patient characteristics of the validation cohort.
Total
patients
 (n=63) 
Bleeding
group
 (n=9) 
No bleeding
group
 (n=56) 
p value
*p<0.05
Patient
Men, n (%) 32 (51)  6 (67) 26 (46) 0.3
Median age 71 74 72 0.48
Age>65 y, n (%) 52 (83)  7 (78) 45 (80) 0.94
Medical history
Hypertension, n (%) 20 (32)  4 (44) 16 (29) 0.3
Chronic kidney disease, n (%) 4 (6)  1 (11) 3 (5) 0.47
Chronic liver disease, n (%) 0 (0) 0 (0) 0 (0) 
Stroke, n (%)  9 (11) 0 (0)  9 (16) 0.34
Bleeding history, n (%) 2 (3)  1 (11) 1 (2) 0.27
Drugs, n (%) 14 (22)  2 (22) 12 (21) 1
Alcoholism, n (%) 0 (0) 0 (0) 0 (0) 
Labial INR, n (%) 1 (2) 0 (0) 1 (2) 0.57
PT-INR 2.01±0.42 2.51±0.28 1.93±0.38 0.001*
HAS-BLED Score (points) 1.56±0.96 1.67±1.12 1.54±0.95 0.004*
Local factor
Incision, n (%) 23 (37)  8 (89) 15 (27) 0.04*
Bone milling, n (%) 17 (27)  6 (67) 11 (20) 0.01
Number of extracted teeth (mean±SD) 1.63±1.26 1.44±0.72 1.67±1.33 0.62
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Figure　3　Risk classification and outcome (OBRS).
Bleeding group No-bleeding group
High-risk OBRS 9 5
Low-risk OBRS 0 49
tithrombotic agents can progress to high-risk procedure.
The effect of warfarin is greater in Japanese subjects;
therefore, therapeutic range of warfarin is set lower in
Japanese population than that in Western populations.
１３
Since the study included Japanese subjects only, investi-
gations of race-based differences should be conducted
before extrapolating OBRS results to other patient
groups. Moreover, large multicentre study is necessary.
In this study, it is likely that system setting would con-
sider haemostasis measures for post-tooth-extraction
bleeding as high expense group of OBRS; in contrast,
few instances of post-tooth-extraction bleeding occurred
among patients in low-risk group, indicating that these
patients do not need to be treated at specialized medical
institutions, even if undergoing treatment with warfarin.
However, measuring PT-INR prior to tooth extraction is
still essential.
To the best of our knowledge, this is the first study to
develop new risk score for post-tooth-extraction bleed-
ings. Since the study was a retrospective cohort study
conducted at a single institution, large-scale prospective
cohort studies, including out patients, are needed in fu-
ture.
Conclusion
PT-INR value, drugs with antiplatelet effects, incision at
the time of tooth extraction, and their interactions were
identified as risk factors that predicted bleeding after
tooth extraction in patients receiving warfarin therapy.
We proposed novel bleeding risk evaluation method
(OBRS) for predicting risk of post-tooth-extraction
bleeding in patients undergoing warfarin therapy.
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